Content » Vol 87, Issue 2

Letter to the Editor

Assessing Clinically Meaningful End Points for the Management of Actinic Keratosis with Diclofenac 3% Gel

Jason K. Rivers, John Wolf
DOI: 10.2340/00015555-0213


This article does not have an abstract.


Supplementary content


Not logged in! You need to login/create an account to comment on articles. Click here to login/create an account.